No Data
No Data
Brazilian aircraft giant Embraer considers introducing a new model
[Aircraft] It is reported that Brazilian aircraft giant Embraer is considering introducing a new model that can counter the oligopoly of the two companies in the jet market spanning nearly 30 years while the US industry Boeing is in a crisis of reliability. According to Embraer's internal evaluation, it is reported that it was determined that the company has technical know-how and manufacturing capacity to develop the first next-generation single-aisle aircraft (narrow body aircraft). In parts manufacturers, etc., speculation about expanding new business partners is likely to increase. <340
BB Tower, etc. [A strange brand seen from changes in turnover]
Stock closing price turnover compared to the previous day*<2342>trans G 263 38 1513600*<3776>BB tower 179 5 15758900*<3891>high paper 2052 141 308200*<9417>smabaru 472 80 270300*<6962>large vacuum 817 34 1107000*<9932>Sugimoto Shoji
Brands that moved the day before part 1 Japan Aviation Electronics Industry, CUC, Metawater, etc.
<コード>Stock name closing price on the 25th ⇒ Hulic <3003> 1424.5 -63.5 1st quarter operating profit decreased 30.5% compared to the previous day. Marubeni Leasing <9763> 3065 +10924 financial results and dividend forecasts for the fiscal year ending March 31, 24 were revised upward. Ishizuka Nitro <5204> operating profit for the fiscal year ending 2682 -16525 is expected to decrease 54.2%. Daiichi Sankyo <4568> 4766 +37 share buying/cancellation with an upper limit of 2.87% of the number of issued shares. Business is growing but stock prices are sluggish. No. 1<
Meta Water, Canon, Avionics, etc.
<4519> Chugai Pharmaceutical 4860-291 continued to decline drastically. Financial results for the first quarter were announced the day before. Core operating income was 102.1 billion yen, down 3.1% from the same period last year, but market consensus has improved due to a cost ratio decline higher than expected. However, sales revenue declined drastically, with a 24.1% decrease from the same period. In addition to the decline in sales due to the completion of deliveries to the Rona Grove government, Babysmo, Alesensa, etc. also fell short of expectations, and overseas shipments of Actemra also seem to have declined due to the effects of biosimilars. sluggish
Avionics --- Continued significant growth, profit forecast for the current fiscal year to exceed market expectations
Avionics (6807) continues to increase drastically. Financial results for the fiscal year ended March 24 were announced the day before, and operating profit was 14.4 billion yen, down 17.9% from the previous fiscal year, reaching 14 billion yen on par with the previous plan. Meanwhile, the plan for the fiscal year ending 25/3 is 17 billion yen, which is a 17.9% increase from the same period, turning into a 2-digit increase in profit. The annual dividend is also planned to be 60 yen, an increase of 5 yen from the previous fiscal year. Operating profit is above the market consensus level of about 15.5 billion yen. We anticipate an increase in sales for the automotive industry and the aerospace/space market, which will be supported by the defense business
Front market [stocks that have moved, stocks that have been created]
*Japan Aviation Electronics Industry<6807> 2548 +217 The profit forecast for the current fiscal year exceeds market expectations. *Ordinary income forecasts were revised upward due to large vacuum <6962> 827 +44 exchange margin recording, etc. *Are Capcom <9697> 2636 +73.5 evoJapan upcoming events also expected. *Is it a supply-demand factor, such as buybacks in the high price range of NIPPATS <5991> 1584 +44? *Eisai <4523> No. 6244 +155 Alzheimer's drug “Rekenbi”
No Data